Blood Test and Lung Nodule Treatment

Trial Objective

Blood Test and Lung Nodule TreatmentResearchers want to know if results of a new blood test, called the Nodify XL2 test, will impact how a physician treats a patient with lung nodules. Study participants will have blood drawn. The blood sample will be analyzed using the Nodify XL2 test. The results of the Nodify XL2 test may help physicians reduce the need for biopsies or invasive procedures on a patient’s  lung nodules.


Active Clinical Trials Currently Recruiting

Who Can Participate

People who are over 40 with newly identified solid lung nodules that are determined to be low to moderate risk of becoming cancerous.

Age: 40+    Gender: Any Gender

Estimated Time Commitment

Up to 2 years, with a total of 5 clinic visits

Trial Contact

For more information, contact:

Jami Henriksen

Jami Henriksen

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

Biodesix, Inc.    

Principal Investigators

Request More Information

By completing this form, you agree to learn more about this study and see if you qualify.

 I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health: